Pharmaxis Results Of U.S. FDA-Ordered Bronchitol Trial To Be Announced
This article was originally published in PharmAsia News
Executive Summary
Pharmaxis scientists are conducting a detailed analysis of the results of a Phase III clinical trial of the Australia firm's Bronchitol (mannitol) for treating cystic fibrosis.